These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27661210)

  • 21. Novel Therapeutic Strategies for Delirium in Patients With Cancer: A Preliminary Study.
    Tanimukai H; Tsujimoto H; Matsuda Y; Tokoro A; Kanemura S; Watanabe M; Tsujio I; Maeda I; Takei K; Nakajima S; Taira T; Tokuyama M; Kai T; Okamoto Y; Goya S; Kashiwagi Y
    Am J Hosp Palliat Care; 2016 Jun; 33(5):456-62. PubMed ID: 25550442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An integrative literature review exploring the clinical management of delirium in patients with advanced cancer.
    Lawley H; Hewison A
    J Clin Nurs; 2017 Dec; 26(23-24):4172-4183. PubMed ID: 28700116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delirium in advanced cancer patients.
    Centeno C; Sanz A; Bruera E
    Palliat Med; 2004 Apr; 18(3):184-94. PubMed ID: 15198131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R).
    Okuyama T; Yoshiuchi K; Ogawa A; Iwase S; Yokomichi N; Sakashita A; Tagami K; Uemura K; Nakahara R; Akechi T;
    Oncologist; 2019 Jul; 24(7):e574-e582. PubMed ID: 30610009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lorazepam Added to Haloperidol Effective for Agitated Delirium in End-of-Life Cancer Patients.
    Shrikant Kulkarni N
    Am Fam Physician; 2018 Feb; 97(4):Online. PubMed ID: 29671522
    [No Abstract]   [Full Text] [Related]  

  • 26. Rational Use of Second-Generation Antipsychotics for the Treatment of ICU Delirium.
    Mo Y; Yam FK
    J Pharm Pract; 2017 Feb; 30(1):121-129. PubMed ID: 26033792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Delirium in Palliative Care: Evidence and Practice].
    Gärtner J; Büche D; Camartin C
    Ther Umsch; 2018 Jul; 75(2):91-100. PubMed ID: 30022723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic treatment of delirium symptoms: A systematic review.
    Sadlonova M; Duque L; Smith D; Madva EN; Amonoo HL; Vogelsang J; Staton SC; von Arnim CAF; Huffman JC; Celano CM
    Gen Hosp Psychiatry; 2022; 79():60-75. PubMed ID: 36375344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delirium at the End of Life.
    Agar M; Bush SH
    Med Clin North Am; 2020 May; 104(3):491-501. PubMed ID: 32312411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role?
    Devlin JW; Skrobik Y
    Harv Rev Psychiatry; 2011; 19(2):59-67. PubMed ID: 21425934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Delirium in patients with cancer].
    Staniszewska A; Kłoszewska I
    Wiad Lek; 2007; 60(1-2):60-3. PubMed ID: 17607970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usage of haloperidol for delirium in cancer patients.
    Akechi T; Uchitomi Y; Okamura H; Fukue M; Kagaya A; Nishida A; Oomori N; Yamawaki S
    Support Care Cancer; 1996 Sep; 4(5):390-2. PubMed ID: 8883234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.
    Bush SH; Kanji S; Pereira JL; Davis DHJ; Currow DC; Meagher D; Rabheru K; Wright D; Bruera E; Hartwick M; Gagnon PR; Gagnon B; Breitbart W; Regnier L; Lawlor PG
    J Pain Symptom Manage; 2014 Aug; 48(2):231-248. PubMed ID: 24480529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delirium in the terminally ill.
    Breitbart W; Strout D
    Clin Geriatr Med; 2000 May; 16(2):357-72. PubMed ID: 10783433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olanzapine vs haloperidol: treating delirium in a critical care setting.
    Skrobik YK; Bergeron N; Dumont M; Gottfried SB
    Intensive Care Med; 2004 Mar; 30(3):444-9. PubMed ID: 14685663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of terminal restlessness: a review of the evidence.
    Kehl KA
    J Pain Palliat Care Pharmacother; 2004; 18(1):5-30. PubMed ID: 15148006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing and Managing Delirium in Cancer Patients.
    Edelstein A; Alici Y
    Oncology (Williston Park); 2017 Sep; 31(9):686-692, III. PubMed ID: 29071696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged delirium managed with risperidone.
    Bourgeois JA; Hilty DM
    Psychosomatics; 2005; 46(1):90-1. PubMed ID: 15765831
    [No Abstract]   [Full Text] [Related]  

  • 39. A perspective on the management of delirium in terminally ill patients on a palliative care unit.
    Fainsinger RL; Tapper M; Bruera E
    J Palliat Care; 1993; 9(3):4-8. PubMed ID: 7903694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients.
    Rea RS; Battistone S; Fong JJ; Devlin JW
    Pharmacotherapy; 2007 Apr; 27(4):588-94. PubMed ID: 17381385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.